Influenza B/Streptococcal co-infection complicated by organizing pneumonia

Wang C Kwok1, Sonia H Y Lam2, Maria P Wong3

  • 1Department of Medicine Queen Mary Hospital, University of Hong Kong Hong Kong SAR China.

Respirology Case Reports
|August 13, 2016
PubMed

Insights

Organizing pneumonia is a rare influenza complication. This case highlights successful treatment with corticosteroids for influenza B and Streptococcus pneumoniae coinfection, suggesting their benefit in similar influenza-associated cases.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Organizing pneumonia (OP) is a rare but serious complication of influenza infections, leading to significant patient morbidity.
  • While OP is known to occur after influenza A, its association with influenza B and bacterial coinfection is less documented.

Observation:

  • This report details the first case of organizing pneumonia following coinfection with influenza B and Streptococcus pneumoniae.
  • The patient presented with clinical and radiological features mirroring those seen in influenza A-associated OP.

Findings:

  • The coinfection of influenza B and Streptococcus pneumoniae led to organizing pneumonia.
  • Treatment with systemic corticosteroids resulted in significant clinical and radiological improvement.

Implications:

  • The findings suggest that clinical and radiological manifestations of OP due to influenza B/Streptococcus pneumoniae coinfection are similar to those seen with influenza A.
  • Early administration of systemic glucocorticosteroids may be beneficial for resolving influenza-associated organizing pneumonia, regardless of the specific influenza strain or coinfecting bacteria.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K